UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Norovirus

Authors
David O Matson, MD, PhD
Miguel G O'Ryan, MD
Neil R Blacklow, MD
Section Editor
Martin S Hirsch, MD
Deputy Editor
Elinor L Baron, MD, DTMH

INTRODUCTION

Norovirus is the most common viral cause of epidemic gastroenteritis worldwide. The first outbreak was described in Norwalk, Ohio, in 1968 [1]. Illness due to norovirus was initially described as "winter vomiting disease" due to its seasonal predilection and preponderance of patients with vomiting as a primary symptom.

The epidemiology, virology, clinical manifestations, diagnosis, pathogenesis, and prevention of norovirus will be reviewed here. Issues related to management of acute viral gastroenteritis in adults are discussed separately. (See "Acute viral gastroenteritis in adults", section on 'Treatment'.)

EPIDEMIOLOGY

Norovirus is the most common viral cause of epidemic gastroenteritis worldwide; it is also a common cause of endemic diarrhea in community settings [2-11].

In the United States, norovirus has become the most common cause of gastroenteritis in adults and children since introduction of rotavirus vaccination [7,12-14]. Each year, norovirus causes 19 to 21 million illnesses, including 570 to 800 deaths, 56,000 to 71,000 hospitalizations, 400,000 emergency department visits, and 1.7 to 1.9 million outpatient visits [15].

Norovirus antibody seroprevalence rises progressively during childhood; more than 90 percent of young adults are seropositive [3,16,17]. However, immunity is not long lasting, and reinfection can occur [18]. Exposure over time to a diversity of norovirus strains may result in repeat infections.

                   

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2017. | This topic last updated: Jul 25, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Robilotti E, Deresinski S, Pinsky BA. Norovirus. Clin Microbiol Rev 2015; 28:134.
  2. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 2011; 60:1.
  3. de Wit MA, Koopmans MP, Kortbeek LM, et al. Etiology of gastroenteritis in sentinel general practices in the netherlands. Clin Infect Dis 2001; 33:280.
  4. Centers for Disease Control and Prevention (CDC). Outbreak of acute gastroenteritis associated with Norwalk-like viruses among British military personnel--Afghanistan, May 2002. MMWR Morb Mortal Wkly Rep 2002; 51:477.
  5. Centers for Disease Control and Prevention (CDC). Norovirus activity--United States, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:41.
  6. Patel MM, Widdowson MA, Glass RI, et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224.
  7. Payne DC, Vinjé J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121.
  8. Centers for Disease Control and Prevention (CDC). Norovirus outbreak among evacuees from hurricane Katrina--Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1016.
  9. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:1776.
  10. Fankhauser RL, Monroe SS, Noel JS, et al. Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002; 186:1.
  11. Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14:725.
  12. Lorrot M, Bon F, El Hajje MJ, et al. Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France. Eur J Clin Microbiol Infect Dis 2011; 30:361.
  13. Bresee JS, Marcus R, Venezia RA, et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis 2012; 205:1374.
  14. Williams DJ, Edwards KM, Payne DC, et al. Decline in gastroenteritis-related triage calls after rotavirus vaccine licensure. Pediatrics 2012; 130:e872.
  15. Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerg Infect Dis 2013; 19:1198.
  16. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 2002; 35:246.
  17. Parker SP, Cubitt WD, Jiang X. Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK. J Med Virol 1995; 46:194.
  18. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 1990; 161:18.
  19. Mounts AW, Ando T, Koopmans M, et al. Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis 2000; 181 Suppl 2:S284.
  20. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991; 325:252.
  21. Bresee JS, Widdowson MA, Monroe SS, Glass RI. Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis 2002; 35:748.
  22. Teunis PF, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol 2008; 80:1468.
  23. Atmar RL, Opekun AR, Gilger MA, et al. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis 2014; 209:1016.
  24. Siebenga JJ, Beersma MF, Vennema H, et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis 2008; 198:994.
  25. Okhuysen PC, Jiang X, Ye L, et al. Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis 1995; 171:566.
  26. Chan MC, Sung JJ, Lam RK, et al. Fecal viral load and norovirus-associated gastroenteritis. Emerg Infect Dis 2006; 12:1278.
  27. Moe CL. Preventing norovirus transmission: how should we handle food handlers? Clin Infect Dis 2009; 48:38.
  28. Costantini VP, Cooper EM, Hardaker HL, et al. Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities. Clin Infect Dis 2016; 62:1.
  29. Graham DY, Jiang X, Tanaka T, et al. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994; 170:34.
  30. Thornhill TS, Kalica AR, Wyatt RG, et al. Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis 1975; 132:28.
  31. Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis 2009; 49:1069.
  32. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med 2004; 351:2417.
  33. Marks PJ, Vipond IB, Carlisle D, et al. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000; 124:481.
  34. Centers for Disease Control and Prevention (CDC). Norovirus outbreak in an elementary school--District of Columbia, February 2007. MMWR Morb Mortal Wkly Rep 2008; 56:1340.
  35. Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis 2008; 47:1202.
  36. Repp KK, Keene WE. A point-source norovirus outbreak caused by exposure to fomites. J Infect Dis 2012; 205:1639.
  37. Repp KK, Hostetler TP, Keene WE. A norovirus outbreak related to contaminated surfaces. J Infect Dis 2013; 208:295.
  38. Centers for Disease Control and Prevention (CDC). Norovirus outbreak associated with ill food-service workers--Michigan, January-February 2006. MMWR Morb Mortal Wkly Rep 2007; 56:1212.
  39. Bonifait L, Charlebois R, Vimont A, et al. Detection and quantification of airborne norovirus during outbreaks in healthcare facilities. Clin Infect Dis 2015; 61:299.
  40. Keswick BH, Satterwhite TK, Johnson PC, et al. Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol 1985; 50:261.
  41. Sukhrie FH, Teunis P, Vennema H, et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis 2012; 54:931.
  42. Franck KT, Nielsen RT, Holzknecht BJ, et al. Norovirus Genotypes in Hospital Settings: Differences Between Nosocomial and Community-Acquired Infections. J Infect Dis 2015; 212:881.
  43. Zlot A, Simckes M, Vines J, et al. Norovirus outbreak associated with a natural lake used for recreation - Oregon, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:485.
  44. Widdowson MA, Cramer EH, Hadley L, et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J Infect Dis 2004; 190:27.
  45. Thornton SA, Sherman SS, Farkas T, et al. Gastroenteritis in US Marines during Operation Iraqi Freedom. Clin Infect Dis 2005; 40:519.
  46. Centers for Disease Control and Prevention (CDC). Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1112.
  47. Green KY, Belliot G, Taylor JL, et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002; 185:133.
  48. Centers for Disease Control and Prevention (CDC). Multistate outbreak of norovirus gastroenteritis among attendees at a family reunion--Grant County, West Virginia, October 2006. MMWR Morb Mortal Wkly Rep 2007; 56:673.
  49. Freeland AL, Vaughan GH Jr, Banerjee SN. Acute Gastroenteritis on Cruise Ships - United States, 2008-2014. MMWR Morb Mortal Wkly Rep 2016; 65:1.
  50. Hall AJ, Wikswo ME, Pringle K, et al. Vital signs: foodborne norovirus outbreaks - United States, 2009-2012. MMWR Morb Mortal Wkly Rep 2014; 63:491.
  51. Centers for Disease Control and Prevention. Reporting and Surveillance for Norovirus. https://www.cdc.gov/norovirus/reporting/index.html (Accessed on March 23, 2017).
  52. Blanton LH, Adams SM, Beard RS, et al. Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J Infect Dis 2006; 193:413.
  53. Kaplan JE, Feldman R, Campbell DS, et al. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health 1982; 72:1329.
  54. Turcios RM, Widdowson MA, Sulka AC, et al. Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. Clin Infect Dis 2006; 42:964.
  55. Verhoef L, Vennema H, van Pelt W, et al. Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. Emerg Infect Dis 2010; 16:617.
  56. Hutson AM, Atmar RL, Estes MK. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 2004; 12:279.
  57. Vinjé J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol 2015; 53:373.
  58. Hardy ME, Kramer SF, Treanor JJ, Estes MK. Human calicivirus genogroup II capsid sequence diversity revealed by analyses of the prototype Snow Mountain agent. Arch Virol 1997; 142:1469.
  59. Jiang X, Espul C, Zhong WM, et al. Characterization of a novel human calicivirus that may be a naturally occurring recombinant. Arch Virol 1999; 144:2377.
  60. Matson DO. Calicivirus RNA Recombination. In: Viral Gastroenteritis: Perspectives in Medical Virology, Desselberger U, Gray J (Eds), Elsevier, Amsterdam 2003. p.555.
  61. Siebenga JJ, Vennema H, Zheng DP, et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 2009; 200:802.
  62. Desai R, Hembree CD, Handel A, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012; 55:189.
  63. Lopman B, Vennema H, Kohli E, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004; 363:682.
  64. Centers for Disease Control and Prevention (CDC). Norovirus activity--United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007; 56:842.
  65. Tu ET, Bull RA, Greening GE, et al. Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin Infect Dis 2008; 46:413.
  66. Centers for Disease Control and Prevention (CDC). Emergence of new norovirus strain GII.4 Sydney--United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:55.
  67. Saito M, Goel-Apaza S, Espetia S, et al. Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis 2014; 58:483.
  68. Matsushima Y, Ishikawa M, Shimizu T, et al. Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill 2015; 20.
  69. de Graaf M, van Beek J, Vennema H, et al. Emergence of a novel GII.17 norovirus – End of the GII.4 era? Euro Surveill 2015; 20.
  70. Lu J, Sun L, Fang L, et al. Gastroenteritis Outbreaks Caused by Norovirus GII.17, Guangdong Province, China, 2014-2015. Emerg Infect Dis 2015; 21:1240.
  71. Lee CC, Feng Y, Chen SY, et al. Emerging norovirus GII.17 in Taiwan. Clin Infect Dis 2015; 61:1762.
  72. Kambhampati A, Payne DC, Costantini V, Lopman BA. Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. Clin Infect Dis 2016; 62:11.
  73. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002; 185:1335.
  74. Rockx BH, Vennema H, Hoebe CJ, et al. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 2005; 191:749.
  75. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548.
  76. Parrino TA, Schreiber DS, Trier JS, et al. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977; 297:86.
  77. Huang P, Farkas T, Marionneau S, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 2003; 188:19.
  78. Halperin T, Vennema H, Koopmans M, et al. No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J Infect Dis 2008; 197:63.
  79. Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann Intern Med 1972; 76:993.
  80. Agus SG, Dolin R, Wyatt RG, et al. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med 1973; 79:18.
  81. Levy AG, Widerlite L, Schwartz CJ, et al. Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterology 1976; 70:321.
  82. Meeroff JC, Schreiber DS, Trier JS, Blacklow NR. Abnormal gastric motor function in viral gastroenteritis. Ann Intern Med 1980; 92:370.
  83. Dolin R, Levy AG, Wyatt RG, et al. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am J Med 1975; 59:761.
  84. Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med 1973; 288:1318.
  85. Schreiber DS, Blacklow NR, Trier JS. The small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J Infect Dis 1974; 129:705.
  86. Widerlite L, Trier JS, Blacklow NR, Schreiber DS. Structure of the gastric mucosa in acute infectious bacterial gastroenteritis. Gastroenterology 1975; 68:425.
  87. Dolin R, Treanor JJ, Madore HP. Novel agents of viral enteritis in humans. J Infect Dis 1987; 155:365.
  88. Estes MK, Prasad BV, Atmar RL. Noroviruses everywhere: has something changed? Curr Opin Infect Dis 2006; 19:467.
  89. Ryder RW, Greenberg H, Singh N, et al. Seroepidemiology of heat-labile enterotoxigenic Escherichia coli and Norwalk virus infections in Panamanians, Canal Zone residents, Apache Indians, and United States Peace Corps volunteers. Infect Immun 1982; 37:903.
  90. Zhu S, Regev D, Watanabe M, et al. Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains. PLoS Pathog 2013; 9:e1003592.
  91. Goller JL, Dimitriadis A, Tan A, et al. Long-term features of norovirus gastroenteritis in the elderly. J Hosp Infect 2004; 58:286.
  92. Lopman BA, Reacher MH, Vipond IB, et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis 2004; 39:318.
  93. Mattner F, Sohr D, Heim A, et al. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 2006; 12:69.
  94. Koo HL, Ajami NJ, Jiang ZD, et al. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis 2009; 48:e75.
  95. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367:2126.
  96. Ghosh N, Malik FA, Daver RG, et al. Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center: a 10-year retrospective study. Infect Dis (Lond) 2017; 49:113.
  97. Echenique IA, Stosor V, Gallon L, et al. Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus. Transpl Infect Dis 2016; 18:98.
  98. Avery RK, Lonze BE, Kraus ES, et al. Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome. Transpl Infect Dis 2017; 19.
  99. Karandikar UC, Crawford SE, Ajami NJ, et al. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol 2016; 97:2291.
  100. Mai H, Gao Y, Cong X, et al. GII.4 Sydney_2012 norovirus infection in immunocompromised patients in Beijing and its rapid evolution in vivo. J Med Virol 2016; 88:224.
  101. Teunis PF, Sukhrie FH, Vennema H, et al. Shedding of norovirus in symptomatic and asymptomatic infections. Epidemiol Infect 2015; 143:1710.
  102. Roddie C, Paul JP, Benjamin R, et al. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis 2009; 49:1061.
  103. Porter CK, Faix DJ, Shiau D, et al. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis 2012; 55:915.
  104. Hu MH, Lin KL, Wu CT, et al. Clinical Characteristics and Risk Factors for Seizures Associated With Norovirus Gastroenteritis in Childhood. J Child Neurol 2017; 32:810.
  105. Phillips G, Tam CC, Rodrigues LC, Lopman B. Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiol Infect 2010; 138:1454.
  106. Jiang X, Wang J, Graham DY, Estes MK. Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol 1992; 30:2529.
  107. Moe CL, Gentsch J, Ando T, et al. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol 1994; 32:642.
  108. Schwab KJ, Estes MK, Neill FH, Atmar RL. Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol 1997; 35:511.
  109. Ando T, Monroe SS, Noel JS, Glass RI. A one-tube method of reverse transcription-PCR to efficiently amplify a 3-kilobase region from the RNA polymerase gene to the poly(A) tail of small round-structured viruses (Norwalk-like viruses). J Clin Microbiol 1997; 35:570.
  110. Kundu S, Lockwood J, Depledge DP, et al. Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin Infect Dis 2013; 57:407.
  111. Ando T, Monroe SS, Gentsch JR, et al. Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J Clin Microbiol 1995; 33:64.
  112. Atmar RL, Neill FH, Romalde JL, et al. Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol 1995; 61:3014.
  113. Atmar RL, Neill FH, Woodley CM, et al. Collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissues by PCR. Appl Environ Microbiol 1996; 62:254.
  114. Atmar RL, Metcalf TG, Neill FH, Estes MK. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl Environ Microbiol 1993; 59:631.
  115. Beuret C. Simultaneous detection of enteric viruses by multiplex real-time RT-PCR. J Virol Methods 2004; 115:1.
  116. Marshall JA, Bruggink LD. Laboratory diagnosis of norovirus. Clin Lab 2006; 52:571.
  117. de Bruin E, Duizer E, Vennema H, Koopmans MP. Diagnosis of Norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 2006; 137:259.
  118. González GG, Liprandi F, Ludert JE. Evaluation of a commercial enzyme immunoassay for the detection of norovirus antigen in fecal samples from children with sporadic acute gastroenteritis. J Virol Methods 2006; 136:289.
  119. Burton-MacLeod JA, Kane EM, Beard RS, et al. Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J Clin Microbiol 2004; 42:2587.
  120. Vinjé J, Vennema H, Maunula L, et al. International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J Clin Microbiol 2003; 41:1423.
  121. Richards AF, Lopman B, Gunn A, et al. Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol 2003; 26:109.
  122. Dimitriadis A, Bruggink LD, Marshall JA. Evaluation of the Dako IDEIA norovirus EIA assay for detection of norovirus using faecal specimens from Australian gastroenteritis outbreaks. Pathology 2006; 38:157.
  123. Dimitriadis A, Marshall JA. Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens. Eur J Clin Microbiol Infect Dis 2005; 24:615.
  124. Herrmann JE, Nowak NA, Perron-Henry DM, et al. Diagnosis of astrovirus gastroenteritis by antigen detection with monoclonal antibodies. J Infect Dis 1990; 161:226.
  125. Elliott EJ. Acute gastroenteritis in children. BMJ 2007; 334:35.
  126. Parashar UD, Nelson EA, Kang G. Diagnosis, management, and prevention of rotavirus gastroenteritis in children. BMJ 2013; 347:f7204.
  127. Kotloff KL, Losonsky GA, Morris JG Jr, et al. Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics 1989; 84:219.
  128. Uhnoo I, Wadell G, Svensson L, Johansson ME. Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 1984; 20:365.
  129. Cunliffe NA, Booth JA, Elliot C, et al. Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis 2010; 16:55.
  130. Rodriguez WJ, Kim HW, Brandt CD, et al. Fecal adenoviruses from a longitudinal study of families in metropolitan Washington, D.C.: laboratory, clinical, and epidemiologic observations. J Pediatr 1985; 107:514.
  131. Krajden M, Brown M, Petrasek A, Middleton PJ. Clinical features of adenovirus enteritis: a review of 127 cases. Pediatr Infect Dis J 1990; 9:636.
  132. Lee TW, Kurtz JB. Prevalence of human astrovirus serotypes in the Oxford region 1976-92, with evidence for two new serotypes. Epidemiol Infect 1994; 112:187.
  133. Noel JS, Lee TW, Kurtz JB, et al. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J Clin Microbiol 1995; 33:797.
  134. Taylor MB, Walter J, Berke T, et al. Characterisation of a South African human astrovirus as type 8 by antigenic and genetic analyses. J Med Virol 2001; 64:256.
  135. Kurtz JB, Lee TW, Craig JW, Reed SE. Astrovirus infection in volunteers. J Med Virol 1979; 3:221.
  136. Midthun K, Greenberg HB, Kurtz JB, et al. Characterization and seroepidemiology of a type 5 astrovirus associated with an outbreak of gastroenteritis in Marin County, California. J Clin Microbiol 1993; 31:955.
  137. Bates PR, Bailey AS, Wood DJ, et al. Comparative epidemiology of rotavirus, subgenus F (types 40 and 41) adenovirus and astrovirus gastroenteritis in children. J Med Virol 1993; 39:224.
  138. Cruz JR, Bartlett AV, Herrmann JE, et al. Astrovirus-associated diarrhea among Guatemalan ambulatory rural children. J Clin Microbiol 1992; 30:1140.
  139. Lew JF, Moe CL, Monroe SS, et al. Astrovirus and adenovirus associated with diarrhea in children in day care settings. J Infect Dis 1991; 164:673.
  140. Moe CL, Allen JR, Monroe SS, et al. Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe. J Clin Microbiol 1991; 29:2390.
  141. Glass RI, Noel J, Mitchell D, et al. The changing epidemiology of astrovirus-associated gastroenteritis: a review. Arch Virol Suppl 1996; 12:287.
  142. Caul EO, Paver WK, Clarke SK. Letter: Coronavirus particles in faeces from patients with gastroenteritis. Lancet 1975; 1:1192.
  143. Jevšnik M, Steyer A, Zrim T, et al. Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis. Virol J 2013; 10:46.
  144. Hyypiä T, Horsnell C, Maaronen M, et al. A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A 1992; 89:8847.
  145. Stanway G, Kalkkinen N, Roivainen M, et al. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 1994; 68:8232.
  146. Wildenbeest JG, Benschop KS, Minnaar RP, et al. Clinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples. Clin Microbiol Infect 2014; 20:O640.
  147. Ludert JE, Hidalgo M, Gil F, Liprandi F. Identification in porcine faeces of a novel virus with a bisegmented double stranded RNA genome. Arch Virol 1991; 117:97.
  148. Ganesh B, Bányai K, Martella V, et al. Picobirnavirus infections: viral persistence and zoonotic potential. Rev Med Virol 2012; 22:245.
  149. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102:12891.
  150. Jin Y, Cheng WX, Xu ZQ, et al. High prevalence of human bocavirus 2 and its role in childhood acute gastroenteritis in China. J Clin Virol 2011; 52:251.
  151. Yamashita T, Kobayashi S, Sakae K, et al. Isolation of cytopathic small round viruses with BS-C-1 cells from patients with gastroenteritis. J Infect Dis 1991; 164:954.
  152. Saikruang W, Khamrin P, Suantai B, et al. Molecular detection and characterization of Aichivirus A in adult patients with diarrhea in Thailand. J Med Virol 2014; 86:983.
  153. Iritani N, Kaida A, Abe N, et al. Detection and genetic characterization of human enteric viruses in oyster-associated gastroenteritis outbreaks between 2001 and 2012 in Osaka City, Japan. J Med Virol 2014; 86:2019.
  154. Levican J, Navas E, Orizola J, et al. Human bocavirus in children with acute gastroenteritis, Chile, 1985-2010. Emerg Infect Dis 2013; 19:1877.
  155. Rovida F, Campanini G, Piralla A, et al. Molecular detection of gastrointestinal viral infections in hospitalized patients. Diagn Microbiol Infect Dis 2013; 77:231.
  156. Chhabra P, Payne DC, Szilagyi PG, et al. Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008-2009. J Infect Dis 2013; 208:790.
  157. Stanway G, Joki-Korpela P, Hyypiä T. Human parechoviruses--biology and clinical significance. Rev Med Virol 2000; 10:57.
  158. Centers for Disease Control and Prevention (CDC). Recurring norovirus outbreaks in a long-term residential treatment facility - Oregon, 2007. MMWR Morb Mortal Wkly Rep 2009; 58:694.
  159. MacCannell T, Umscheid CA, Agarwal RK, et al. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 2011; 32:939.
  160. Barclay L, Park GW, Vega E, et al. Infection control for norovirus. Clin Microbiol Infect 2014; 20:731.
  161. Baehner F, Bogaerts H, Goodwin R. Vaccines against norovirus: state of the art trials in children and adults. Clin Microbiol Infect 2016; 22 Suppl 5:S136.
  162. American Academy of Pediatrics. Norovirus and other human calicivirus infections. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.573.
  163. Tuladhar E, Hazeleger WC, Koopmans M, et al. Reducing viral contamination from finger pads: handwashing is more effective than alcohol-based hand disinfectants. J Hosp Infect 2015; 90:226.
  164. Centers for Disease Control and Prevention. General Information about Norovirus. https://www.cdc.gov/hai/organisms/norovirus.html (Accessed on February 17, 2017).
  165. American Academy of Pediatrics. Children in out-of-home child care. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.132.
  166. Centers for Disease Control and Prevention. Preventing Norovirus Infection. https://www.cdc.gov/norovirus/preventing-infection.html (Accessed on February 14, 2017).